The Enterprise Value as of November 2024 (TTM) for Larimar Therapeutics, Inc. (LRMR) is 464.16M

According to Larimar Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 464.16M. This represents a change of -99.56% compared to the average of 104.72B of the last 4 quarters.

Larimar Therapeutics, Inc. (LRMR) Historical Enterprise Value (quarterly & annually)

How has LRMR Enterprise Value performed in the past?

The mean historical Enterprise Value of Larimar Therapeutics, Inc. over the last ten years is 145.25M. The current 464.16M Enterprise Value has changed 31.86% with respect to the historical average. Over the past ten years (40 quarters), LRMR's Enterprise Value was at its highest in in the September 2024 quarter at 417.90B. The Enterprise Value was at its lowest in in the December 2014 quarter at -50545000.00.

Larimar Therapeutics, Inc. (LRMR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Larimar Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Larimar Therapeutics, Inc. (LRMR) Average Enterprise Value

How has LRMR Enterprise Value performed in the past?

The current Enterprise Value of Larimar Therapeutics, Inc. (LRMR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Larimar Therapeutics, Inc. (LRMR) Enterprise Value vs. Peers

How is LRMR’s Enterprise Value compared to its peers?

Larimar Therapeutics, Inc.’s Enterprise Value is less than Vaxcyte, Inc. (12.58B), less than Syndax Pharmaceuticals, Inc. (1.51B), less than Merus N.V. (3.00B), greater than Sutro Biopharma, Inc. (390.61M), greater than Immuneering Corporation (35.42K), less than Centessa Pharmaceuticals plc (1.73B), less than Celcuity Inc. (618.91M), greater than Ikena Oncology, Inc. (47.83M), greater than Spero Therapeutics, Inc. (5.19M), greater than Bolt Biotherapeutics, Inc. (37.89M), greater than Coherus BioSciences, Inc. (222.40M), less than Gracell Biotechnologies Inc. (5.49B), greater than Neoleukin Therapeutics, Inc. (-6333315.00), greater than Surrozen, Inc. (6.81M), less than Keros Therapeutics, Inc. (1.86B), greater than Kezar Life Sciences, Inc. (41.94M), greater than Cabaletta Bio, Inc. (10.02M), greater than Homology Medicines, Inc. (-103303255.00), less than Day One Biopharmaceuticals, Inc. (865.54M), less than Alector, Inc. (477.12M),

Build a custom stock screener for Larimar Therapeutics, Inc. (LRMR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Larimar Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Larimar Therapeutics, Inc. (LRMR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Larimar Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.